Abington Memorial Hospital (Abington-Jefferson Health) Selected for Early Supply Program of Andexxa
Filed under: News ·
Abington Memorial Hospital (Abington-Jefferson Health) Selected for Early Supply Program of Andexxa (reversal agent for the blood thinners Xarelto & Eliquis) On May 3, 2018, the Food and Drug Administration (FDA) approved the use of Andexxa, the first available antidote for patient’s taking the blood thinners Xarelto or Eliquis and who experience serious bleeding. Abington … Read more